Abstract:Introduction: Gastrointestinal (GI) malignancies, such as cholangiocarcinoma, pancreatic carcinoma, and metastatic colorectal carcinoma, have a poor prognosis and effective therapeutic approaches are still challenging. Checkpoint inhibition with PD-1 or PDL-1 antibodies revealed promising results in different tumor entities; however, only few patients with GI tumors can potentially benefit from PD1/PDL1 inhibiting immunotherapy. Further immunotherapeutic strategies for GI malignancies are urgently needed. The aim of this study was to demonstrate that in vitro activation of the immune checkpoint CD40/CD40L can improve DC action towards bile duct, pancreas, and colorectal carcinoma. Methods: Human DC were isolated from buffy coats from healthy donors, pulsed with tumor lysates and then transduced with adenoviruses encoding human CD40L (Ad-hCD40L). Using transwell assays, the effects of (m)CD40L on DC immunoactivation compared to (s)CD40L were analyzed. Surface marker and cytokine/chemokine expression were measured by flow cytometry, ELISA and cytokine arrays. Capacity of Ad-hCD40L-transduced DC to induce tumor-specific effector cells was tested using MTT proliferation assay and cytotoxicity assays. Apoptosis induction on tumor cells after culturing with supernatants of Ad-hCD40L-transduced DC was analyzed by flow cytometry. Results: Ad-hCD40L transduction induced a high expression of (s)CD40L and (m)CD40L on DC and seemed to induce a strong cellular CD40/CD40L interaction among DC, leading to the formation of cell aggregates. Due to the CD40/CD40L interaction, a significant upregulation of DC maturation markers and a Th1-shift on cytokines/chemokines in the supernatant of DC were achieved. Interestingly, a pure Th1-shift was only achieved, when a cellular CD40/CD40L interaction among DC took place. (s)CD40L induced almost no upregulation of maturation markers and rather resulted in a Th2-cytokine expression, such as IL-10. Correspondingly, (m)CD40L-expressing DC led to significant proliferation and stimulation of tumor-specific effector cells with increased cytotoxicity towards pancreatic, bile duct and colorectal tumor cells. Supernatants of Ad-hCD40L-transduced DC could also induce apoptosis in the different tumor cells in vitro. Conclusion: Stimulation of the immune checkpoint CD40L/CD40 by endogenous expression of (m)CD40L provokes a cellular interaction, which increases the immunomodulatory capacity of DC. A Th1 cytokine/chemokine expression is induced, leading to a significant proliferation and enabling cytotoxicity of effector cells towards human bile duct, pancreatic and colorectal tumor cells. The present data point to the promising approach for DC-based immunotherapy of gastrointestinal malignances by activating the CD40/CD40L immune checkpoint.

Functional Modulating Effect of CD40 Ligand on CD40-transfected Human Lung Carcinomas

Functional Significance of CD40 and CD40 Ligand Linking on Human Lung Cells

CD40 is a regulator for vascular endothelial growth factor in the tumor microenvironment of glioma.

More efficient induction of antitumor T cell immunity by exosomes from CD40L gene-modified lung tumor cells.

[388] PEG10 IS OVEREXPRESSED IN HEPATOCELLULAR CARCINOMA AND IS A POTENTIAL TARGET FOR HEPATOCELLULAR CARCINOMA GENE THERAPHY

Gene Transfer of CD40-Ligand to Human Dendritic Cells Induces Growth Arrest and Apoptosis of Tumor Cells Mediated by Up-Regulated TRAIL and its Receptors.

Effect of sCD40L combined with vinorelbine on lung adenocarcinoma cell A549]

Construction and expression of a eukaryotic expression plasmid containing human CD40 ligand in human hepatocellular carcinoma cell line HepG2 and its effect on apoptosis

Harnessing the potential of CD40 agonism in cancer therapy

Expression of Human Soluble CD40 Ligand in Pichia Pastoris and Its Effects on Dendritic Cells and Malignant B Cells.

Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40 Ligand Linkage

Membrane-Bound CD40L Promotes Senescence and Initiates Senescence-Associated Secretory Phenotype via NF-κB Activation in Lung Adenocarcinoma

Expression Analysis Of Cdc42 In Lung Cancer And Modulation Of Its Expression By Curcumin In Lung Cancer Cell Lines

Regulation Effects of T Cell Activated Factors on the Expressions of MHC- Ⅰ Molecules and Costimulatory Molecule on Lung Cancer Cell

Mechanisms of CD40-dependent cDC1 licensing beyond costimulation

The Effects of CD40L on the Phenotypes and IL-12 Secretion of B Lymphocytes

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells

The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia

CD137 ligand-mediated reverse signaling inhibits proliferation and induces apoptosis in non-small cell lung cancer

CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions

The intrinsic role and mechanism of tumor expressed-CD38 on lung adenocarcinoma progression